In adidtion, in patients with delayed graft function, there was no fall in serum NGAL or cystatin C. Therefore, we concluded that NGAL should be investigated as a potential early, sensitive marker of kidney impairment/injury, which might provide an additional accurate measure of kidney impairment in CKD and among transplant recipients, particularly at advanced stages. The gene discussed is LCN2; the disease is chronic kidney disease.